| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 78,196 | 69,213 | 58,795 | | Cost of Revenue | 20,847 | 17,301 | 15,361 | | | Gross Profit | 57,349 | 51,912 | 43,434 | | | Operating Expenses | | Research Development | 10,243 | 13,718 | 7,904 | | Selling General and Administrative | 56,295 | 56,356 | 43,429 | | Non Recurring | 462 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (9,651) | (18,162) | (7,899) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,853) | 1,711 | 2,183 | | Earnings Before Interest And Taxes | (11,504) | (16,451) | (5,716) | | Interest Expense | 52 | 3 | 14 | | Income Before Tax | (11,556) | (16,454) | (5,730) | | Income Tax Expense | (502) | (194) | (247) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (11,054) | (16,260) | (5,483) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (11,054) | (16,260) | (5,483) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($11,054) | ($16,260) | ($5,483) |
|
1.48% Nasdaq 
Income Statement
